» Articles » PMID: 16618119

The Two NK-1 Binding Sites Correspond to Distinct, Independent, and Non-interconvertible Receptor Conformational States As Confirmed by Plasmon-waveguide Resonance Spectroscopy

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2006 Apr 19
PMID 16618119
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Two nonstoichiometric ligand binding sites have been previously reported for the NK-1 receptor, with the use of classical methods (radioligand binding and second messenger assays). The most populated (major, NK-1M) binding site binds substance P (SP) and is related to the adenylyl cyclase pathway. The less populated (minor, NK-1m) binding site binds substance P, C-terminal hexa- and heptapeptide analogues of SP, and the NK-2 endogenous ligand, neurokinin A, and is coupled to the phospholipase C pathway. Here, we have examined these two binding sites with plasmon-waveguide resonance (PWR) spectroscopy that allows the thermodynamics and kinetics of ligand-receptor binding processes and the accompanying structural changes of the receptor to be monitored, through measurements of the anisotropic optical properties of lipid bilayers into which the receptor is incorporated. The binding of the three peptides, substance P, neurokinin A, and propionyl[Met(O(2))(11)]SP(7-11), to the partially purified NK-1 receptor has been analyzed by this method. Substance P and neurokinin A bind to the reconstituted receptor in a biphasic manner with two affinities (K(d1) = 0.14 +/- 0.02 nM and K(d2) = 1.4 +/- 0.18 nM, and K(d1) = 5.5 +/- 0.7 nM and K(d2) = 620 +/- 117 nM, respectively), whereas only one binding affinity (K(d) = 5.5 +/- 0.4 nM) could be observed for propionyl[Met(O(2))(11)]SP(7-11). Moreover, binding experiments in which one ligand was added after another one has been bound to the receptor have shown that the binding of these ligands to each binding site was unaffected by the fact that the other site was already occupied. These data strongly suggest that these two binding sites are independent and non-interconvertible on the time scale of these experiments (1-2 h).

Citing Articles

Impact of membrane lipid polyunsaturation on dopamine D2 receptor ligand binding and signaling.

Jobin M, De Smedt-Peyrusse V, Ducrocq F, Baccouch R, Oummadi A, Pedersen M Mol Psychiatry. 2023; 28(5):1960-1969.

PMID: 36604603 DOI: 10.1038/s41380-022-01928-6.


Plasmon Waveguide Resonance: Principles, Applications and Historical Perspectives on Instrument Development.

Rascol E, Villette S, Harte E, Alves I Molecules. 2021; 26(21).

PMID: 34770851 PMC: 8588475. DOI: 10.3390/molecules26216442.


The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy.

Majkowska-Pilip A, Halik P, Gniazdowska E Pharmaceutics. 2019; 11(9).

PMID: 31480582 PMC: 6781293. DOI: 10.3390/pharmaceutics11090443.


Improved Detection of Plasmon Waveguide Resonance Using Diverging Beam, Liquid Crystal Retarder, and Application to Lipid Orientation Determination.

Isaacs S, Harte E, Alves I, Abdulhalim I Sensors (Basel). 2019; 19(6).

PMID: 30901964 PMC: 6471420. DOI: 10.3390/s19061402.


The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors.

Boye K, Pujol N, Alves I, Chen Y, Daubon T, Lee Y Nat Commun. 2017; 8(1):1571.

PMID: 29146996 PMC: 5691136. DOI: 10.1038/s41467-017-01686-y.


References
1.
Salamon Z, MacLeod H, Tollin G . Coupled plasmon-waveguide resonators: a new spectroscopic tool for probing proteolipid film structure and properties. Biophys J. 1997; 73(5):2791-7. PMC: 1181181. DOI: 10.1016/S0006-3495(97)78308-5. View

2.
Tollin G, Salamon Z, Hruby V . Techniques: plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactions. Trends Pharmacol Sci. 2003; 24(12):655-9. DOI: 10.1016/j.tips.2003.10.010. View

3.
Salamon Z, Tollin G . Graphical analysis of mass and anisotropy changes observed by plasmon-waveguide resonance spectroscopy can provide useful insights into membrane protein function. Biophys J. 2004; 86(4):2508-16. PMC: 1304098. DOI: 10.1016/S0006-3495(04)74306-4. View

4.
Mueller P, RUDIN D, Tien H, WESCOTT W . Reconstitution of cell membrane structure in vitro and its transformation into an excitable system. Nature. 1962; 194:979-80. DOI: 10.1038/194979a0. View

5.
Kenakin T . Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol Sci. 2003; 24(7):346-54. DOI: 10.1016/S0165-6147(03)00167-6. View